Parabilis Medicines, Inc. Common Stock (PBLS) is a publicly traded the market company. As of July 22, 2026, PBLS trades at $31.02 with a market cap of $3.67B and a P/E ratio of 0.00. PBLS moved +2.36% today. Year to date, PBLS is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $24.51 to $34.47. Analyst consensus is strong buy with an average price target of $41.75. Rallies surfaces PBLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover PBLS: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $41.75.
| Metric | Value |
|---|---|
| Price | $31.02 |
| Market Cap | $3.67B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $34.47 |
| 52-Week Low | $24.51 |
| Volume | 287.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover PBLS: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.75.